ACETAMINOPHEN AND IBUPROFEN
Generic: ACETAMINOPHEN, IBUPROFEN
L.N.K. InternationalManufacturer
ORALRoute
ACETAMINOPHENActive Substance
2025-12-11Original Approval
ACETAMINOPHEN AND IBUPROFEN is FDA application ANDA220126, sponsored by LNK INTL INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
48 reports
2
DRUG EFFECTIVE FOR UNAPPROVED INDICATION
30 reports
3
THERAPEUTIC PRODUCT EFFECT INCOMPLETE
27 reports
4
DRUG EFFECT LESS THAN EXPECTED
15 reports
5
UNDERDOSE
13 reports
6
OVERDOSE
10 reports
7
INCORRECT DOSE ADMINISTERED
9 reports
8
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION
8 reports
9
OFF LABEL USE
8 reports
10
HYPERSENSITIVITY
7 reports